Project Grant R43CA275537
Award Date
9/6/23
Completion Date
8/31/24
Dollars Obligated
$400K
Federal Agency
National Cancer Institute
Federal Grant Program
93.394
Assistance Type
Project Grant
Place of Performance
Illinois, USA
Similar Awards
The National Cancer Institute (NCI) awarded a $400,000 Project Grant under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to O2M Technologies LLC, a small for-profit company specializing in advanced oxygen imaging technology. The grant supports the development of a "Multifunctional EPRI Instrument to Advance Therapies in Biomedical Sciences." The project aims to create a new electron paramagnetic resonance imaging (EPRI) instrument that can simultaneously acquire...
This Project Grant award from the National Cancer Institute (NCI) under the Cancer Detection and Diagnosis Research program (CFDA 93.394) provides $295,747 to Doseoptics LLC to develop a new surgical imaging system called Pressure-Enhanced Sensing Surgery (PRESS). The PRESS system utilizes a clinically approved contrast agent to enable real-time visualization of tissue oxygenation levels during surgical procedures, with the goal of enhancing the precision and efficacy of oncologic surgeries. The...
The National Institutes of Health (NIH) National Cancer Institute (NCI) awarded a $407,113 Project Grant under the Cancer Biology Research (CFDA 93.396) program to Trustees of Boston University. The award, effective from September 1, 2024 to August 31, 2027, supports the development of a new bio-orthogonal mid-infrared photothermal (MIP) imaging technology to quantitatively measure molecular events in cancer cells at the subcellular level. Key objectives include building a library of...
The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), awarded a $399,491 Project Grant under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to Northridge Tri-Modality Imaging Inc. The grant will fund the upgrade of the company's gantry-based combined X-ray CT and fluorescent tomography (FLT) imaging system to add bioluminescence tomography (BLT) capability. This will enable the system to acquire co-registered 3D X-ray CT, FLT, and BLT images...
This $435,827 Project Grant from the National Cancer Institute (NCI) under the CFDA 93.394 Cancer Detection and Diagnosis Research program supports research conducted by New York University (NYU) School of Medicine to develop deep learning methods for analyzing mass spectrometry imaging (MSI) data. The goal is to make MSI data more accessible to existing machine learning workflows by expanding the dimensionality of the data structure to treat each metabolite or lipid as an individual "color...
This $400,000 federal Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) supports the development of a new "MCAM-96" computational microscope platform by Ramona Optics Inc., a small disadvantaged business. The MCAM-96 is designed to enable parallelized, high-throughput 3D imaging of tumor organoids at speeds 50x faster than current microscopes. The system will also capture parallelized live-cell video assays to analyze dynamic...
The federal Project Grant award R01CA301488 was provided by the National Cancer Institute (CFDA 93.396 Cancer Biology Research program) to Carnegie Mellon University to develop an integrated ultrahigh-throughput 3D volumetric super-resolution imaging system. This $632,300 award aims to combine a multiscale fluorescence mesoscope with magnify expansion microscopy to enable rapid, large-area 3D imaging with exceptional subcellular detail. The goal is to study interactions between cancer and immune...
The National Cancer Institute (NCI) awarded a $222,027 Project Grant (CFDA 93.396 - Cancer Biology Research) to the University of Pittsburgh to develop a novel computational imaging algorithm that can characterize the mechanobiological properties of the tumor microenvironment. The key objectives are to: Develop a computational imaging algorithm that can quantitatively capture the intrinsic mechanobiological properties of the cellular and acellular components within 3D tumor microenvironments,...
This federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $811,503 to develop an innovative radiation imaging tool. The goal is to create a quantitative, real-time isotopic spectroscopy imaging device that can visualize the spatial distribution and decay of targeted alpha therapy molecules used in cancer treatments....
The National Cancer Institute (NCI) awarded a $599,191 Project Grant (CFDA 93.394 - Cancer Detection and Diagnosis Research) to the University of California, San Diego (UCSD) to develop and validate new perfusion measurement techniques using 3D Dynamic Contrast-Enhanced Ultrasound (3D DCE-US) imaging. The goal is to characterize complex tumor vascular properties and detect microvascular changes following cancer therapy, with the aim of improving non-invasive bedside diagnostics and treatment...